Nephro Care India Ltd
Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes
in the treatment of kidney- related diseases[1]
- Market Cap ₹ 137 Cr.
- Current Price ₹ 83.0
- High / Low ₹ 156 / 50.0
- Stock P/E 27.0
- Book Value ₹ 34.5
- Dividend Yield 0.00 %
- ROCE %
- ROE 4.92 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 88.74 | |
| 80.42 | |
| Operating Profit | 8.32 |
| OPM % | 9.38% |
| 1.55 | |
| Interest | 0.16 |
| Depreciation | 5.07 |
| Profit before tax | 4.64 |
| Tax % | 27.37% |
| 3.37 | |
| EPS in Rs | 2.04 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Equity Capital | 16.49 |
| Reserves | 40.37 |
| 0.00 | |
| 15.86 | |
| Total Liabilities | 72.72 |
| 34.01 | |
| CWIP | 0.53 |
| Investments | 11.76 |
| 26.42 | |
| Total Assets | 72.72 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 2.21 | |
| -0.43 | |
| 0.05 | |
| Net Cash Flow | 1.83 |
| Free Cash Flow | -5.59 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 48% |
Ratios
Consolidated / View Standalone
| Mar 2026 | |
|---|---|
| Debtor Days | 24.84 |
| Inventory Days | 31.68 |
| Days Payable | 92.84 |
| Cash Conversion Cycle | -36.31 |
| Working Capital Days | -4.11 |
| ROCE % |
Insights
In beta| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Permanent employees employees ・Standalone data |
|
||
| Hospital bed capacity beds ・Standalone data |
|||
| IPD revenue mix % ・Standalone data |
|||
| Number of clinics clinics ・Standalone data |
|||
| OPD revenue mix % ・Standalone data |
|||
| Patients treated patients ・Standalone data |
|||
| Hospital bed occupancy % ・Standalone data |
|||
| OT procedures procedures ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Regulation 74(5) certificate for quarter ended 30 September 2026; no dematerialisation or rematerialisation requests.
-
Structural Digital Database
- SDD compliance certificate filed for quarter ended 30 September 2026; no non-compliances observed.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
- Company states corporate governance provisions under Regulation 27(2) are not applicable after NSE EMERGE listing.
-
Shareholders meeting
- 12th AGM voting results: all 3 resolutions passed on September 25, 2026.
-
Shareholders meeting
- 12th AGM held on 25 Sept 2026; audited FY26 statements approved, two directors reappointed.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
-
Annual Report 2024
from nse
Concalls
-
Aug 2025PPT
Business Overview:[1][2]
NCIL provides comprehensive medical services for renal patients as a one-stop treatment center in Kolkata. It offers clinical and lifestyle solutions for renal insufficiency, covering lifestyle, physiological, and spiritual wellness. The company specializes in non-invasive services.